Aprea Therapeutics Inc logo

APRE - Aprea Therapeutics Inc News Story

$4.17 -0.2  -3.9%

Last Trade - 7:35pm

Sector
Healthcare
Size
Small Cap
Market Cap £66.1m
Enterprise Value £2.11m
Revenue £n/a
Position in Universe 5221st / 6849

BRIEF-Aprea Therapeutics Q4 Loss Per Share $0.73

Tue 16th March, 2021 8:59pm
March 16 (Reuters) - Aprea Therapeutics Inc  APRE.O :
    * APREA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND PROVIDES UPDATE ON BUSINESS OPERATIONS
    * Q4 LOSS PER SHARE $0.73
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.64 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX9pv7yv 
Further company coverage:  APRE.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.